Choroidal Thickness Measurements During Central Serous Chorioretinopathy (CSCR) Treatment

University Hospital Regensburg18 enrolled

Overview

The purpose of this study is to determine changes in choroidal thickness in patients with Central Serous Chorioretinopathy (CSCR) during the first 3 months after initial diagnosis via Enhanced-Depth-Imaging-Spectral-Domain-Optical-Coherence-Tomography (EDI-OCT). Study hypothesis: Since exudative changes in the choroid seem to constitute the primary pathology of CSCR, changes in choroidal thickness compared to healthy eyes should be present and be visible using EDI-OCT.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Choroidal Thickness

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with initial diagnosis of CSCR and no treatment so far Exclusion Criteria: * Therapy (drugs/laser) due to CSCR

Locations (1)

University Hospital Regensburg

Regensburg, Bavaria, Germany

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.